Although this conclusion should be treated with caution, given the limited number of cases and the borderline significance level, the observation that the number of women starting HRT during intervention was similar in the tamoxifen and placebo arms of the study seems to exclude the bias of an uneven HRT prescription.
← all excerpts
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.
1
—
—